General
Preferred name
OXYPHENCYCLIMINE
Synonyms
OXYPHENCYCLIMINE HYDROCHLORIDE ()
Oxyphencyclimine ()
NSC-528449 ()
Oxyphencyclimine hcl ()
Oxiphencyclimine Chloride ()
Daricon ()
P&D ID
PD010078
CAS
125-52-0
125-53-1
Tags
natural product
drug
available
Approved by
FDA
Drug Status
approved
withdrawn
Drug indication
Peptic ulcer
Max Phase
Phase 4
First approval
1982
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Oxyphencyclimine is a synthetic anticholinergic drug with gastrointestinal antispasmodic and antisecretory action. (GtoPdb)
DESCRIPTION Oxyphencyclimine is a muscarinic cholinergic receptor antagonist and trade name is called as Daricon. Now it is applicated for the treatment of peptic ulcers and the relief of smooth muscle spasms in gastrointestinal. (BOC Sciences Bioactive Compounds)
DESCRIPTION The hydrochloride salt form of Oxyphencyclimine which could influence the peripheral parasympathetic system and increase the stomach secretions. (BOC Sciences Bioactive Compounds)
Compound Sets
15
ChEMBL Approved Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Guide to Pharmacology
NPC Screening Collection
ReFrame library
The Spectrum Collection
Withdrawn 2.0
External IDs
42
Properties
(calculated by RDKit )
Molecular Weight
344.21
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
1
Rotatable Bonds
5
Ring Count
3
Aromatic Ring Count
1
cLogP
2.73
TPSA
62.13
Fraction CSP3
0.6
Chiral centers
1.0
Largest ring
6.0
QED
0.83
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
ATC
A03AA01
Therapeutic Class
Anticholinergic Agents
Solubility
DMSO: ≥ 30 mg/mL
Soluble in DMSO
Source data